Abstract
Enteric fever is a public health problem with the upsurge in the occurrence of Salmonella isolates that are resistant to ciprofloxacin. In this study, a total of 284 blood culture isolates of S. Paratyphi A were investigated. Of these isolates, 281 (98.9%) were nalidixic acid resistant. A high rate (6.3%) of high-level resistance (≥4 μg/mL) was found to ciprofloxacin. The isolates with ciprofloxacin minimum inhibitory concentrations (MICs) of ≥12 μg/mL had 4 mutations, 2 mutations within the quinolone resistance-determining region of gyrA and 2 mutations also in parC. According to the Clinical Laboratory Standards Institute 2012 MIC breakpoints, 75.0% of isolates were resistant to ciprofloxacin. Finally, 3 major pulsed-field gel electrophoresis patterns were observed among the S. Paratyphi A isolates. The spread of fluoroquinolone resistant S. Paratyphi A necessitates a change toward 'evidence-based' treatment for enteric fever. The research provides a perspective on the increasing prevalence of antimicrobial resistant S. Paratyphi A isolates in this region of India.
Original language | English |
---|---|
Pages (from-to) | 222-227 |
Number of pages | 6 |
Journal | Indian Journal of Medical Microbiology |
Volume | 34 |
Issue number | 2 |
DOIs | |
Publication status | Published - Apr 2016 |
Externally published | Yes |
Keywords
- Blood culture
- Salmonella Paratyphi A
- ciprofloxacin
- gyrA
- multi-drug resistant
ASJC Scopus subject areas
- Microbiology (medical)